Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone + formoterol versus fluticasone in adults with COPD
ACTRN12609000850279Phase 3Not yet recruiting
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Fluticasone + formoterol with Fluticasone (2 arms). Primary endpoint: Forced expiratory volume in one second (FEV1). Planned start Apr 2010; status: not yet recruiting.
02
Drugs
fluticasoneformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12609000850279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000850279.